ComplexINC brings together expertise from academia and industry to design, validate and roll-out powerful tools, high-throughput methods and technologies for the production of complex biologics (medicinal products).  ComplexINC uses a wide range of synthetic biology approaches for the development of new expression systems using baculoviruses, mammalian, yeast and insect cells lines, and state-of-the-art process engineering. By increasing the accessibility of proteins, protein complexes and complex biologics, it will in turn benefit pharmaceutical interests in areas such as drug discovery, vaccinations and therapeutics.